Protective action of l-carnitine on cardiac mitochondrial function and structure against fatty acid stress

Biochemical and Biophysical Research Communications

Volumn 412, Issue 1, 2011, Pages 61-67

  Oyanagi, Eri ^a   Yano, Hiromi ^b   Uchida, Masataka ^b   Utsumi, Kozo ^a   Sasaki, Junzo ^a  

^a OKAYAMA UNIVERSITY   (Japan)

^b KAWASAKI UNIVERSITY OF MEDICAL WELFARE   (Japan)

Author keywords

Oxidation; Cytochrome c; Heart; Palmitoyl CoA

Indexed keywords

CARNITINE; CYTOCHROME C; FATTY ACID; OLIGOMYCIN; OXFENICINE; PALMITOYL COENZYME A HYDROLASE; ROTENONE;

ANIMAL CELL; ARTICLE; CELL DAMAGE; CELL FUNCTION; CELL PROTECTION; CELL STRESS; CELL SWELLING; CONTROLLED STUDY; MEMBRANE DEPOLARIZATION; MEMBRANE PERMEABILITY; MITOCHONDRIAL RESPIRATION; MITOCHONDRION; NONHUMAN; OXYGEN CONSUMPTION; PREMEDICATION; PRIORITY JOURNAL; RAT; STRESS;

ANIMALS; CARNITINE; FATTY ACIDS; MITOCHONDRIA, HEART; MITOCHONDRIAL SWELLING; OXYGEN CONSUMPTION; PALMITOYL COENZYME A; PERMEABILITY; RATS; STRESS, PHYSIOLOGICAL; VITAMIN B COMPLEX;

RATTUS;

EID: 80051785011     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2011.07.039     Document Type: Article

References (38)

1. Erkkila A., de Mello V.D., Risérus U., et al. Dietary fatty acids and cardiovascular disease: an epidemiological approach. Prog. Lipid Res. 2008, 47:172-187.
2. Rennison J.H., Van Wagoner D.R. Impact of dietary fatty acids on cardiac arrhythmogenesis. Circ. Arrhythm. Electrophysiol. 2009, 2:460-469.
3. Coor P.B., Gross R.W., Sobel B.E. Amphipathic metabolites and membrane dysfunction in ischemic myocardium. Circ. Res. 1984, 55:135-154.
4. Lopaschuk G.D., Hansen C.A., Neely J.R. Fatty acid metabolism in hearts containing elevated levels of CoA. Am. J. Physiol. 1986, 250:H351-H359.
5. Bremer J. Carnitine-metabolism and functions. Physiol. Rev. 1983, 63:1420-1480.
6. Savitha S., Panneerselvam C. Mitochondrial membrane damage during aging process in rat heart: potential efficacy of l-carnitine and DL alpha lipoic acid. Mech. Ageing Dev. 2006, 127:349-355.
7. Izgut-Uysal V.N., Agaç A., Karadogan I., et al. Peritoneal macrophages function modulation by l-carnitine in aging rats. Aging Clin. Exp. Res. 2004, 16:337-341.
8. Thangasamy T., Subathra M., Sittadjody S., et al. Role of l-carnitine in the modulation of immune response in aged rats. Clin. Chim. Acta 2008, 389:19-24.
9. Takahashi K., Kitano A., Akiba Y. Effect of l-carnitine on proliferative response and mRNA expression of some of its associated factors in splenic mononuclear cells of male broiler chicks. Anim. Sci. J. 2010, 81:215-222.
10. Imai S., Matsui K., Nakazawa M., et al. Anti-arrhythmic effects of (-)-carnitine chloride and its acetyl analogue on canine late ventricular arrhythmia induced by ligation of the coronary artery as related to improvement of mitochondrial function. Br. J. Pharmacol. 1984, 82:533-542.
11. Rizzon P., Biasco G., Di Biase M., et al. High doses of l-carnitine in acute myocardial infarction: metabolic and antiarrhythmic effects. Eur. Heart J. 1989, 10:502-508.
12. Cacciatore L., Cerio R., Ciarimboli M., et al. The therapeutic effect of l-carnitine in patients with exercise-induced stable angina: a controlled study. Drugs Exp. Clin. Res. 1991, 17:225-235.
13. Cave M.C., Hurt R.T., Frazier T.H., et al. Obesity, inflammation, and the potential application of pharmaconutrition. Nutr. Clin. Pract. 2008, 23:16-34.
14. Flanagan J.L., Simmons P.A., Vehige J., et al. Role of carnitine in disease. Nutr. Metab. 2010, 7:30.
15. Narula J., Pandey P., Arbustini E., et al. Apoptosis in heart failure: release of cytochrome c from mitochondria and activation of caspase-3 in human cardiomyopathy. Proc. Natl. Acad. Sci. USA 1999, 96:8144-8149.
16. Sparagna G.C., Hickson-Bick D.L., Buja L.M., et al. A metabolic role for mitochondria in palmitate-induced cardiac myocyte apoptosis. Am. J. Physiol. Heart Circ. Physiol. 2000, 279:H2124-H2132.
17. Furuno T., Kanno T., Arita K., et al. Roles of long chain fatty acids and carnitine in mitochondrial membrane permeability transition. Biochem. Pharmacol. 2001, 62:1037-1046.
18. Oyanagi E., Yano H., Kato Y., et al. l-Carnitine suppresses oleic acid-induced membrane permeability transition of mitochondria. Cell Biochem. Funct. 2008, 26:778-786.
19. Di Paola M., Lorusso M. Interaction of free fatty acids with mitochondria: coupling, uncoupling and permeability transition. Biochim. Biophys. Acta 2006, 1757:1330-1337.
20. Mirandola S.R., Melo D.R., Saito A., et al. 3-Nitropropionic acid-induced mitochondrial permeability transition: comparative study of mitochondria from different tissues and brain regions. J. Neurosci. Res. 2010, 88:630-639.
21. Ohnishi S.T., Ohnishi T., Muranaka S., et al. A possible site of superoxide generation in the complex I segment of rat heart mitochondria. J. Bioenerg. Biomembr. 2005, 37:1-15.
22. Yano H., Oyanagi E., Kato Y., et al. l-Carnitine is essential to β-oxidation of quarried fatty acid from mitochondrial membrane by PLA2. Mol. Cell. Biochem. 2010, 342:95-100.
23. Bielefeld D.R., Vary T.C., Neely J.R. Inhibition of carnitine palmitoyl-CoA transferase activity and fatty acid oxidation by lactate and oxfenicine in cardiac muscle. J. Mol. Cell. Cardiol. 1985, 17:619-625.
24. Riedl S.J., Salvesen G.S. The apoptosome: signaling platform of cell death. Nat. Rev. Mol. Cell Biol. 2001, 8:405-413.
25. Nishimura M., Okimura Y., Fujita H., et al. Mechanism of 3-nitropropionic acid-induced membrane permeability transition of isolated mitochondria and its suppression by l-carnitine. Cell Biochem. Funct. 2008, 26:881-891.
26. Hulsmann W.C., Dubelaar M.L., Lamers J.M.J., et al. Protection by acyl-carnitine and phenylmethylsulfonyl fluoride of rat heart subjected to ischemia and reperfusion. Biochim. Biophys. Acta 1985, 847:62-66.
27. Reichmann H., Lindeneiner N.V. Carnitine analysis in normal human red blood cells, plasma, and muscle tissue. Eur. Neurol. 1994, 34:40-43.
28. Dlasková A., Hlavatá L., Jezek J., et al. Mitochondrial complex I superoxide production is attenuated by uncoupling. Int. J. Biochem. Cell Biol. 2008, 40:2098-2109.
29. Hudson S., Tabet N. Acetyl-l-carnitine for dementia. Cochrane Database Syst. Rev. 2003, 2:CD003158.
30. Tominaga H., Katho H., Odagiri K., et al. Different effects of palmitoyl-l-carnitine and palmitoyl-CoA on mitochondrial function in rat ventricular myocytes. Am. J. Physiol. Heart Circ. Physiol. 2008, 295:H105-H112.
31. Nishihara Y., Utsumi K. 4-Chloro-4′-biphenylol as an uncoupler and an inhibitor of mitochondrial oxidative phosphorylation. Biochem. Pharmacol. 1987, 36:3453-3457.
32. Schönfeld P., Bohnensack R. Fatty acid-promoted mitochondrial permeability transition by membrane depolarization and binding to the ADP/ATP carrier. FEBS Lett. 1997, 420:167-170.
33. Weiss J.N., Korge P., Honda H.M., et al. Role of the mitochondrial permeability transition in myocardial disease. Circ. Res. 2003, 93:292-301.
34. Bernardi P., Penzo D., Wojtczak L. Mitochondrial energy dissipation by fatty acids. Mechanisms and implications for cell death. Vitam. Horm. 2002, 65:97-126.
35. Korge P., Honda H.M., Weiss J.N. Effects of fatty acids in isolated mitochondria: implications for ischemic injury and cardioprotection. Am. J. Physiol. Heart Circ. Physiol. 2003, 285:H259-H269.
36. Reda E., D'Iddio S., Nicolai R., et al. The carnitine system and body composition. Acta Diabetol. 2003, 40:S106-S113.
37. Zamzami N., Susin S.A., Marchetti P., et al. Mitochondrial control of nuclear apoptosis. J. Exp. Med. 1996, 183:1533-1544.
38. Scarabelli T.M., Knight R., Stephanou A., et al. Clinical implications of apoptosis in ischemic myocardium. Curr. Prob. Cardiol. 2006, 31:181-264.